Home Search
seizure - search results
If you're not happy with the results, please do another search
Electroshock therapy and alterations in hippocampal structural connections
According to the University of California, alterations in hippocampal structural connections differentiate responders of electroshock therapy in depression.
A new study in people with major...
Genetic study points to potential epilepsy therapy
Newly identified drugs are promising candidates for epilepsy therapy as they directly target the genetic basis of the disease.
In order to create a better...
Neurosteer: introducing a novel brain activity monitor
Neurosteer has developed a three-electrode neurological monitor that provides multiple brain activity biomarkers.
Neurosteer has the mission to improve the quality of brain disorder care...
It’s time for the UK to rethink its approach to medical cannabis
Producing and exporting the most amount of medical cannabis in the world - why is medical cannabis still being denied to patients in the...
What do you know about Zellweger spectrum disorders?
Zellweger UK explains how the charity is working to support research into Zellweger spectrum disorders.
The Zellweger Spectrum Disorders (ZSD) comprise a group of genetic...
Tilray exports 2:100 CBD oil to the United Kingdom
Tilray® Inc., a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing...
Putting patients first by making cannabinoid medicinal products available
Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same
Focusing on patients, their...
The Canadian Cannabis Act: what does it mean for legalisation elsewhere?
In a history-making political decision, Canada is currently preparing for the legalisation of recreational cannabis, known as the Cannabis Act, which would make it...
Advancing cannabinoid therapies through research
Canada’s medical cannabis company Tilray defines a medical path for cannabinoid use
Tilray is actively pursuing the daunting goal of delivering innovative, safe and effective...
Diagnosing mucopolysaccharidoses diseases in young people
This booklet was written by Professor Dr Francois Eyskens of the PCMA vzw, the metabolic laboratory, and the Center of Inherited Metabolic Diseases at...
Towards legalisation
As more and more countries legalise the use of cannabis for medical purposes, Health Europa Quarterly highlights recent research into its possible therapeutic benefits.
The...
